VBS ASX Chart
Snapshot
Vectus Biosystems Limited (VBS) is developing a treatment for fibrosis and high blood pressure, which includes the treatment for three of the largest diseases in the fibrotic market, namely heart, kidney and liver diseases. The Company has also developed technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | -45.67% |
vs ASX 200 (1yr) | -54.05% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | MMJ / MEM / ACR |
EPS | -$0.044 |
DPS | $0.00 |
Book Value Per Share | $0.066 |
Broker Consensus
Please see the Broker Consensus page.
Top Market Index News
Announcements
Corporate Overview
Corporate Details
Head Office | North Ryde NSW 2113 |
Website | www.vectusbiosystems.com.au |
Registry | BoardRoom |
Auditor | UHY Haines Norton Sydney |
Date Listed | 23 Feb 2016 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
28/08/2024 | Report (Prelim) |
28/08/2024 | Report (Annual) |
21/02/2025 | Report (Interim) |
Former Company Names
- Vectus Biosystems Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
VBS directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of VBS directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Bernard stang | 16/08/2023 | 2,560,500 | 4.81 |
Karen Duggan | 16/08/2023 | 3,278,500 | 6.16 |
Maurie Stang | 16/08/2023 | 4,858,952 | 9.14 |
Kefford Holdings Pty Ltd | 16/08/2023 | 5,178,668 | 9.73 |
Regal Funds Management Pty Ltd | 04/12/2023 | 4,483,896 | 8.43 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
04-12-23 | Regal Funds Management Pty Ltd | 26,114 | 9.43 | 8.43 |
27-06-23 | Kefford Holdings Pty Ltd | 528,668 | 8.83 | 9.83 |
08-06-23 | Kefford Holdings Pty Ltd | 701,679 | 7.62 | 8.83 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.440 | 30 June |
2022 | $0.985 | 30 June |
2021 | $1.35 | 30 June |
2020 | $0.720 | 30 June |
2019 | $0.340 | 28 June |
2018 | $0.850 | 29 June |
2017 | $1.40 | 28 June |
2016 | $1.36 | 28 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.